Bcl-2 antagonist BDA-366, Purity ≥98%

Cat. No.: X23-10-ZQ014

Bcl-2 antagonist BDA-366, Purity ≥98%

Synonym: 1909226-00-1; 142645-19-0; BDA-366; BDA366; 1-[[(2S)-3-(Diethylamino)-2-hydroxypropyl]amino]-4-[[(2S)-2-oxiranylmethyl]amino]-9,10-anthracenedione; Bcl-2 antagonist

  • CAS Number: 142645-19-0
  • Compound CID: 91826545
Product Size
2 mg; 5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
BDA-366 specifically inhibits the function of the anti-apoptotic proteins, thereby promoting apoptosis in cancer cells.
Molecular Weight
423.5
Molecular Formula
C24H29N3O4
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
BDA-366 can be used to modulate of Bcl-2 family proteins to assess cancer cell sensitivity.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0